3Filing Date: Sep 10, 2026
West Pharmaceutical Services (WST)
Initial Statement of Beneficial Ownership
View SEC Filing
ACC: 0000105770-26-000106
Total Value$0
Trades1
Insiders1
Transaction Details
Lagarde Michel
President and CEO, Director·Direct
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After7.85K
Post-Transaction Holdings
Lagarde Michel · President and CEO, Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 7.85K | - |
Original SEC Filing Textexpand_more
=== SEC Form 3 — Statement of Changes in Beneficial Ownership ===
Document Type: 3
Period of Report: 2026-08-31
--- Issuer ---
Name: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
--- Reporting Owner ---
Name: Lagarde Michel
CIK: 0001518973
Role: Director, Officer (President and CEO)
--- Holdings ---
[Holding #1]
Security: Common Stock
Ownership: D (Direct)
--- Signature ---
/s/ /s/ Louis Lalli, as an agent for Michel Lagarde (2026-09-10)